Zonovate 1500 Unit (Turoctocog Alfa KIT) 1500 UNIT

Zonovate 1500 Unit is a pharmaceutical kit containing Turoctocog Alfa, used for managing bleeding episodes in hemophilia B. This intravenous medication is designed to support clotting and is manufactured by Novo Nordisk Canada Inc.

Strength

1500 UNIT

Pack Size

4ML

Manufacturer / TM Owner

NOVO NORDISK CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Zonovate 1500 Unit is primarily used for the treatment and prevention of bleeding episodes in individuals with hemophilia B. Hemophilia B is a genetic disorder that affects blood clotting. Turoctocog Alfa, the active ingredient, works by replacing the missing clotting factor IX, which helps to control bleeding. This medication is often used in situations where rapid clotting is necessary, such as during surgery or after an injury.

Side Effects

Common effects of Zonovate 1500 Unit may include localized reactions at the injection site, such as redness or swelling. Some users might experience mild to moderate headaches or nausea. These effects are generally temporary and should subside as the body adjusts to the medication. If any severe or persistent effects occur, it is important to consult a healthcare provider.

Precautions & Warnings

Zonovate 1500 Unit should be handled with care, ensuring proper storage and administration. It is crucial to follow the instructions provided by a healthcare professional for safe use. Individuals with known allergies to Turoctocog Alfa or any of the kit's components should avoid using this medication. Always inform your healthcare provider about any pre-existing conditions or medications you are currently taking.

Avoid Interactions

Zonovate 1500 Unit may interact with certain medications, particularly those that affect blood clotting. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Alcohol consumption should be avoided as it can increase the risk of bleeding. Always consult a healthcare professional for personalized advice.

Frequently Asked Questions

Zonovate 1500 Unit is used to manage and prevent bleeding episodes in individuals with hemophilia B.

Zonovate 1500 Unit is administered intravenously, typically by a healthcare professional.

Common effects may include localized reactions at the injection site, headaches, or nausea.

It is important to consult a healthcare provider before using Zonovate 1500 Unit with other medications.

Precautions include proper storage, administration, and informing your healthcare provider about any allergies or pre-existing conditions.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.